GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History
This cross-sectional study examines how use of glucagon-like peptide-1 (GLP-1) receptor agonists varies among US adults with diabetes with or without a history of cancer.
Authors
- Bismarck C.L. Odei (ORCID: https://orcid.org/0000-0002-3776-697X)
- Fumiko Chino (ORCID: https://orcid.org/0000-0003-0498-488X)
- Olinto Linares-Perdomo (ORCID: https://orcid.org/0009-0006-4344-7795)
- Damon Klebe (ORCID: https://orcid.org/0009-0001-8425-4029)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Huntsman Cancer Institute (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-10-07
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.37813
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00